Gene · 1287
Papers2,056
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,056
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic stratification reveals COL4A variants and spontaneous remission in Egyptian children with proteinuria in the first 2 years of life. | Acta Paediatr | 2023 | 36847718 | PubTator, text mining | PubMed |
| A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people. | Front Med (Lausanne) | 2023 | 36844206 | PubTator, text mining | PubMed |
| Thyroid hormone action controls multiple components of cell junctions at the ventricular zone in the newborn rat brain. | Front Endocrinol (Lausanne) | 2023 | 36843608 | PubTator, text mining | PubMed |
| miRNAs: The Road from Bench to Bedside. | Genes (Basel) | 2023 | 36833241 | PubTator, text mining | PubMed |
| Role of PI3K-AKT Pathway in Ultraviolet Ray and Hydrogen Peroxide-Induced Oxidative Damage and Its Repair by Grain Ferments. | Foods | 2023 | 36832881 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms of Pathogenesis Underlying Inherited Retinal Dystrophies. | Biomolecules | 2023 | 36830640 | PubTator, text mining | PubMed |
| Identification of a basement membrane-based risk scoring system for prognosis prediction and individualized therapy in clear cell renal cell carcinoma. | Front Genet | 2023 | 36816030 | PubTator, text mining | PubMed |
| An Alport Syndrome Journey: From Powerless to Empowered - A Patient Perspective. | Glomerular Dis | 2023 | 36814521 | PubTator, text mining | PubMed |
| Identification and functional characterization of a novel truncating splicing variant in COL4A5 gene causing X-linked Alport syndrome with astigmatism. | Chin Med J (Engl) | 2023 | 36805600 | PubTator, text mining | PubMed |
| Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. | PLoS One | 2023 | 36800380 | PubTator, text mining | PubMed |
| The role of genetic testing in the diagnostic workflow of pediatric patients with kidney diseases: the experience of a single institution. | Hum Genomics | 2023 | 36782285 | PubTator, text mining | PubMed |
| Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice. | Int J Mol Sci | 2023 | 36769148 | PubTator, text mining | PubMed |
| ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization. | Cancers (Basel) | 2023 | 36765910 | PubTator, text mining | PubMed |
| Immunological evaluation of young unvaccinated patients with Turner syndrome after COVID-19. | Int J Infect Dis | 2023 | 36758851 | PubTator, text mining | PubMed |
| Pathogenic variants of Alport syndrome and monogenic diabetes identified by exome sequencing in a family. | Hum Genome Var | 2023 | 36732323 | PubTator, text mining | PubMed |
| Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria. | Pediatr Nephrol | 2023 | 36715773 | PubTator, text mining | PubMed |
| Renal Genetics Clinic: 3-Year Experience in the Cleveland Clinic. | Kidney Med | 2023 | 36712315 | PubTator, text mining | PubMed |
| Long-Term Simulation of Microgravity Induces Changes in Gene Expression in Breast Cancer Cells. | Int J Mol Sci | 2023 | 36674696 | PubTator, text mining | PubMed |
| Pathogenic variant detection rate by whole exome sequencing in Thai patients with biopsy-proven focal segmental glomerulosclerosis. | Sci Rep | 2023 | 36646731 | PubTator, text mining | PubMed |
| Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management. | Int J Nephrol Renovasc Dis | 2023 | 36636322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1287/papers?page=20